La Jolla, CA, United States of America

Sobol E Robert

This inventor holds 1 USPTO granted patent. Top assignee: Novarx Corporation. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sobol E Robert. Retrieved from https://idiyas.com/inventor/sobol-e-robert

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sobol E Robert: Innovator in Cancer Immunotherapy

Introduction

Sobol E Robert is a notable inventor based in La Jolla, CA (US). He has made significant contributions to the field of cancer treatment through his innovative approaches to enhancing tumor cell immunity. His work focuses on stimulating the immune response in subjects to combat cancer effectively.

Latest Patents

Sobol E Robert holds 1 patent for his invention titled "Compositions and methods for enhanced tumor cell immunity in vivo." This invention provides a method for preventing or reducing the severity of cancer by stimulating the subject's immune response against the disease. The method involves administering tumor cells that are genetically modified to inhibit the expression of immunosuppressive agents, thereby enhancing the immune response.

Career Highlights

Robert is associated with Novarx Corporation, where he applies his expertise in cancer immunotherapy. His innovative methods have the potential to change the landscape of cancer treatment, offering new hope to patients.

Collaborations

He has collaborated with notable colleagues, including Fakhrai Habib and Dorigo Oliver, to advance research in this critical area of medicine.

Conclusion

Sobol E Robert's contributions to cancer immunotherapy exemplify the impact of innovative thinking in medicine. His work continues to inspire advancements in the fight against cancer.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…